Rights and permissions
About this article
Cite this article
Mitoxantrone monotherapy appears to be an alternative to combination chemotherapy in patients with high-risk metastatic breast cancer. Pharmacoecon. Outcomes News 260, 11 (2000). https://doi.org/10.1007/BF03275447
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03275447